
You are watching a 25-second preview
Log in to keep watching
Your 25-second video preview has ended.
to continue watching, please Log In or Register:
Anti-VEGF with Targeted PRP
Jonathan Prenner, MD, interviews David M. Brown, MD, about a DAVE trial in which researchers used targeted PRP in combination with anti-VEGF therapy to improve outcomes in patients with DME. Researchers hypothesized that by targeting VEGF-producing tissue, one could reduce treatment burden. Dr. Brown compares visual acuity outcomes in patients with anti-VEGF therapy and PRP with patients receiving anti-VEGF monotherapy.
7,438 video views since 11/17/2015.
112,946 total series views.
These programs are not affiliated with the official program of AAO 2015.
Comments (0)